🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Afuresertib is an AKT inhibitor, a new class of agents under development th...
Status
Completed
Location
Arizona Oncology Associates
Start Date
2020-06-09
Trial ID
NCT04374630
Treatments Being Tested
Afuresertib, an AKT inhibitor, has shown in vitro and in vivo activity in m...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-08-13
Trial ID
NCT02177682
Treatments Being Tested
PhI Dose Escalation with BOIN design in advanced Solid Tumor with Triple co...
Status
Completed
Location
The first affiliated hopsital of bengbu medical college
Start Date
2021-06-12
Trial ID
NCT05390710
Treatments Being Tested
This is a Phase Ib, open-label, dose-escalation study to determine the Maxi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-10
Trial ID
NCT02240212
Treatments Being Tested
Study LAE205INT3101 is a Phase Ib/III study to evaluate the efficacy and sa...
Status
Active Not Recruiting
Location
Providence St. Johns Health Center
Start Date
2022-02-18
Trial ID
NCT04851613
Treatments Being Tested
This study adopts a single-center, single-dose, non-randomized, open-label ...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2022-08-06
Trial ID
NCT05489744
Treatments Being Tested
This open-label, 2-part Phase I/ randomized Phase II multi-center study is ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-11
Trial ID
NCT02235740
Treatments Being Tested
This study is being conducted to measure the relative bioavailability of th...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-05
Trial ID
NCT02040480
Treatments Being Tested
This multicenter, non-randomized, open-label, treatment continuation or 'ro...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02-08
Trial ID
NCT01531894
Treatments Being Tested
The combination treatment of protein kinase B (AKT) inhibitor, afuresertib,...
Status
Completed
Location
Urological Associates of Southern Arizona
Start Date
2019-09-13
Trial ID
NCT04060394
Treatments Being Tested